The role and significance of YKL-40 in mucopathological remodeling in eosinophilic chronic rhinosinusitis
International Immunopharmacology · 2026-07 · 181 · 116734
DOI: 10.1016/j.intimp.2026.116734 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-07. Verfasst von Jing He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China. Hauptthemen laut MEDLINE: Chitinase-3-Like Protein 1, Rhinosinusitis, Nasal Mucosa, Eosinophilia. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Affiliated Hospital of Southwest Medical University, Southwest Medical University.
Abstract (Originalsprache)
OBJECTIVE: Medical and surgical treatments for eosinophilic chronic rhinosinusitis (ECRS) yield suboptimal efficacy, and the disease carries a high postoperative recurrence rate. Currently, there is a lack of histopathological and molecular markers for early identification of its characteristics. YKL-40, a chitinase-like protein, has been shown to be significantly elevated in ECRS patients and it is correlated with disease severity in previous studies. However, the role and mechanism of YKL-40 in promoting inflammation and tissue pathological changes in ECRS remain unclear. This study aimed to investigate the expression and correlation of YKL-40, TGF-β1, and fibrosis-related markers in ECRS patients and mouse models, and explore their regulatory mechanism in mucosal pathological remodeling, with unified diagnostic criteria for ECRS applied throughout. METHODS: An ECRS mouse model was established using ovalbumin (OVA) + Aspergillus protease (PA). ELISA, HE/Masson staining, immunohistochemistry, RT-qPCR, and Western Blot were used to detect inflammatory and remodeling-related indicators in mouse and human nasal mucosal tissues. Primary human ECRS nasal mucosal epithelial cells were isolated, and YKL-40 knockdown combined with TGF-β1 inhibitor intervention was performed to verify the regulatory relationship between YKL-40 and TGF-β1 signaling. RESULTS: ECRS with nasal polyps (ECRSwNP) patients showed higher preoperative and postoperative VAS scores, blood eosinophil indicators, and YKL-40 expression than non-ECRS patients. YKL-40 was positively correlated with disease severity, blood eosinophils, and submucosal collagen volume fraction (CVF) in ECRSwNP. The protein levels of TGF-β1, α-SMA, Collagen I, and Collagen III were significantly upregulated in ECRSwNP nasal polyps and positively correlated with YKL-40 expression. ECRS mice exhibited increased eosinophil infiltration, collagen deposition, and elevated levels of IL-4, IL-13, YKL-40, and TGF-β1. Antagonizing YKL-40 or TGF-β1 in mice attenuated Th2 inflammation, eosinophil infiltration, and collagen deposition. In primary ECRS epithelial cells, YKL-40 knockdown significantly downregulated TGF-β1, α-SMA, Collagen I, and Collagen III expression, with further inhibition observed after combined TGF-β1 blockade. CONCLUSIONS: YKL-40 is highly expressed in ECRS and positively correlated with disease severity and tissue fibrosis. YKL-40 synergizes with TGF-β1 to promote Th2-type inflammation and nasal mucosal pathological remodeling in ECRS. Targeted inhibition of the YKL-40/TGF-β1 axis alleviates mucosal inflammation and fibrosis, suggesting that YKL-40 may serve as a promising biomarker and therapeutic target for ECRS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
- Department of Otolaryngology Head and Neck Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China. Electronic address: qing_lzmc@163.com.
- Department of Otolaryngology Head and Neck Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China. Electronic address: baoyilin_swmu@163.com.
Förderung
- Affiliated Hospital of Southwest Medical University
- Southwest Medical University
Zitieren
APA
He, J., Tang, X., Feng, H., Liao, J., Wang, Y., Wang, D., Qin, G., & Bao, Y. (2026). The role and significance of YKL-40 in mucopathological remodeling in eosinophilic chronic rhinosinusitis. International Immunopharmacology, 181, 116734. https://doi.org/10.1016/j.intimp.2026.116734
Vancouver
He J, Tang X, Feng H, Liao J, Wang Y, Wang D, et al. The role and significance of YKL-40 in mucopathological remodeling in eosinophilic chronic rhinosinusitis. International Immunopharmacology. 2026;181:116734. doi:10.1016/j.intimp.2026.116734
BibTeX
@article{He2026,
author = {He, Jing and Tang, Xin and Feng, Huajun and Liao, Jiangxue and Wang, Yuanyuan and Wang, Dingting and Qin, Gang and Bao, Yilin},
title = {The role and significance of YKL-40 in mucopathological remodeling in eosinophilic chronic rhinosinusitis},
journal = {International Immunopharmacology},
year = {2026},
volume = {181},
pages = {116734},
doi = {10.1016/j.intimp.2026.116734}
}
EUVIMED